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Background: Evidence exists for the effectiveness of cognitive behaviour therapy for psychosis with moderate
effect sizes, but the evidence for cognitive behaviour therapy specifically for distressing voices is less convincing.
An alternative symptom-based approach may be warranted and a body of literature has explored distressing voices
from an interpersonal perspective. This literature has informed the development of relating therapy and findings
from a case series suggested that this intervention was acceptable to hearers and therapists.
Methods/Design: An external pilot randomized controlled trial (RCT) comparing outcomes for 15 patients receiving
16 hours (weekly sessions of one hour) of relating therapy and their usual treatment with 15 patients receiving only
their usual treatment. Participants will be assessed using questionnaires at baseline, 16 weeks (post-intervention),
and 36 weeks (follow-up).
Discussion: Expected outcomes will include a refined study protocol and an estimate of the effect size to inform
the sample size of a definitive RCT. If evidence from a fully powered RCT suggests that relating therapy is effective,
the therapy will extend the range of evidence-based psychological therapies available to people who hear
distressing voices.
Trial registration: Current Controlled Trials ISRCTN registration number 44114663. Registered on 13 June 2013.
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The experience of hearing voices (verbal ‘auditory halluci-
nations’) is one of the prominent features of schizophrenia
in current systems of diagnostic classification [1]. Voice
hearing is reported to occur in approximately 70% of pa-
tients with this diagnosis [2], although the experience is
also common in other mental health conditions such as
post-traumatic stress disorder and borderline personality
disorder [3]. National Institute for Health and Care Excel-
lence (NICE) guidance in the UK recommends that psy-
chological therapy in the form of cognitive behavioral
therapy (CBT) should be offered to all patients who have
a diagnosis of schizophrenia [4]. Although this is appropri-
ate in the case of psychosis more broadly, where an evi-
dence base exists for moderate effects [5], the impact of
CBT for psychosis specifically on distressing voices is less
convincing [6]. Therefore, consistent with a symptom-* Correspondence: mih21@sussex.ac.uk
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unless otherwise stated.based approach [7], a voice-specific approach may be war-
ranted. A recent review [6] was conducted of 16 published
randomized controlled trials (RCTs) of CBT for psychosis
that have reported at least one psychometrically validated
outcome measure specifically related to voice hearing.
The review found that the majority of studies failed to
show a significant effect of CBT on voice hearing, and
most of those that reported significant effects did so in
the context of methodological weaknesses. Only one
study reported an effect using a robust methodology.
Interestingly, this was the only study that focused ex-
clusively on voice hearing [8]. A factor that may have
limited the effect of CBT upon voice hearing concerns
outcome measurement - early trials used measures of
voice frequency and severity, despite CBT not focusing
upon the eradication of voices. The authors conclude by
calling for more robustly designed RCTs of CBT aimed
specifically at distressing voices. They draw attention
to the potential for the integration of other psycho-
therapeutic techniques that have shown early promiseal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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trying to understand and adapt the interpersonal-like
relationships that can develop with voices (see [9,10] for
a review).
There is an evolving body of literature that has explored
the experience of hearing voices from an interpersonal per-
spective, examining the interaction that can occur between
the hearer and the voice(s) that is heard. Findings suggest
that hearers, regardless of diagnosis, can have integrated,
personally coherent relationships with their voices [11].
Two studies using social rank theory found marked differ-
entials of power and social rank between the hearer and the
voice, which place the voice in a dominant position, and
mirror perceptions of self in relation to significant social
others [12,13]. However, whilst there has been a focus on
dominance, research has paid less attention to the role of
intimacy and closeness within relationships with voices. If
relationships with voices do mirror relationships in the so-
cial world, they are likely to be imbued with all the com-
plexity and idiosyncrasy of social relationships. Relating
theory [14] proposes that relating occurs on two axes: a ver-
tical ‘power’ axis characterized at each polar end by ‘upper’
and ‘lower’ (analogous to power differentials), and a hori-
zontal ‘proximity’ axis characterized at each polar end by
‘close’ and ‘distant’. Studies that have explored voice hearing
experiences through the lens of relating theory report that
distressing voices are perceived as relating dominantly and
intrusively [15-17], and are responded to through distant
relating from the hearer. Mirroring has also been found be-
tween proximity styles of relating to voices and those of the
hearers within their social relationships [18].
Collectively, this body of research suggests that voi-
ces can be understood within interpersonal frameworks.
This conceptualization has given rise to a new gener-
ation of therapeutic approaches that seek to modify the
hearer-voice relationship. A pilot RCT [8] that looked at
a therapeutic approach to address the power dynamic
with voices that issue commands (cognitive therapy for
command hallucinations [CTCH]) found significant re-
ductions in compliance behaviour within the therapy
group, and this finding has been replicated in a definitive
trial [19]. A therapeutic focus upon closeness and intimacy
has been developed by Hayward et al. [16] in the form of
relating therapy (RT) which aims to re-balance the hearer-
voice relationship with regard to both power and prox-
imity. Findings from a case series suggested that RT was
acceptable to hearers who experienced persistent and dis-
tressing voices [16,20]. Consistent with the call for evalua-
tions of effectiveness to be methodologically rigorous [6],
RT should now be evaluated within an RCT design.
Research objectives and hypotheses
The main objective of the study will be to inform the de-
velopment of a phase III definitive trial [21]. Specifically,this external pilot RCT will establish recruitment, reten-
tion, and follow-up rates to the trial, assess levels of adher-
ence with the treatment, and establish treatment effect
size relative to treatment-as-usual. This information will
be used to finalize the design of the therapy protocol and
the study protocol for the phase III trial.
This external pilot RCT is, by definition, underpow-
ered to detect statistically significant effects. Voice-related
distress, rather than voice activity (such as loudness or
frequency) or voice attributions (such as beliefs about the
origin of voices), is the primary target of the therapy.
Therefore, the primary hypothesis for the definitive trial
is that RT added to treatment-as-usual will reduce the
distress associated with voice hearing compared with
treatment-as-usual on its own.
Secondary hypotheses for the definitive trial are that
RT will lead to: 1) Reductions in voice-related distress
relative to the control condition that will be maintained
over at least three months; 2) Reductions in voice-
related distress that will be mediated by improvements
in relating to and/or by voices (improvements in relat-
ing defined as reductions in voice dominance and intru-
siveness, and hearer distance - measured by the Voice
and You [VAY]questionnaire); 3) Improvements in re-
covery (measured by the Choice of outcome in CBT for
psychoses [CHOICE] questionnaire), relating to people
in the social world (measured by the shorter version
of the Persons Relating to Others Questionnaire
[PROQ3]), and mood and anxiety (measured by the
Hospital Anxiety and Depression Scale [HADS]); and 4)
Improvements in relating to people in the social world
will be associated with improvements in relating to
and/or by voices (improvements in relating defined as
reductions in voice dominance and intrusiveness, and
hearer distance - measured by the Voice and You
[VAY] questionnaire).
Methods/Design
An external pilot RCT will compare the outcomes for
patients receiving the RT intervention (in addition to
their usual treatment) to outcomes for patients receiving
only their usual treatment. Participants who consent will
be randomized to either RT (plus treatment-as-usual)
or to treatment-as-usual (TAU) only (see Figure 1).
Randomization will be conducted by a statistician in-
dependent to the research team. Outcomes will be assessed
at baseline (pre-randomization - Time 0), 16 weeks (post-
intervention - Time 1), and 36 weeks (follow-up - Time 2).
Time 1 and 2 assessments will be conducted blind by a re-
searcher independent of the therapy process. Adherence
to the therapy protocol will be assessed by an independent
rater assessing a random selection of early, middle, and
late recorded sessions using a modified version of the
cognitive therapy checklist [22].
Figure 1 Flow diagram for R2V trial.
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The study aims to recruit approximately 30 patients from
an NHS mental health trust in the south of the UK.
Allowing for attrition from the study, there will be at least
12 completer participants per condition, in line with rec-
ommendations for pilot RCTs [22]. Inclusion criteria re-
quire that participants have been hearing distressing
voices for at least one year, irrespective of diagnosis, and
score 3 or above on either the intensity of distress item or
the amount of distress item on the Psychotic Symptoms
Rating Scale - Auditory Hallucinations Scale (PSYRATS-
AHRS) [23] at the time of consent. People will be ex-
cluded on the grounds of organic illness, a primary diag-
nosis of substance misuse, or are currently receiving
psychological therapy for distressing voices. Each partici-
pant will give informed consent before entering the trial.
Planned intervention
The intervention will consist of a maximum of 16 hours
(weekly sessions of one hour) of individual RT. The ther-
apy protocol consists of three phases:
Phase 1: socialization to RT and its implications for the
interrelating between hearer and voice. Use of chapter 3
from Overcoming Distressing Voices [24] to guide discus-
sions about relationships in terms of power and proximity,
and linking this discussion to participant’s experiences of
relating to people and distressing voices. Consideration of
the typical ways of responding to negative relating (giving
in, fighting back, and trying to escape). Introduction of the
possibility of relating differently to voices.Phase 2: exploration of themes within the relational
history of the hearer and their experience of relation-
ships with voices, and interpersonal relating within the
family and social environment (identifying any promin-
ent themes, such as abuse, disempowerment, or rivalry).
Development of connections across all forms of relating.
If appropriate and desired, generating formulation(s)
that link past and present forms of relating.
Phase 3: exploration and development of assertive ap-
proaches to relating (to the voice and socially). Selection of
a relationship to be the focus of intervention. Use of chap-
ter 7 from Overcoming Distressing Voices [24] to explore
current utterances of chosen voice or person, responses to
these utterances, identifying responses as passive, aggres-
sive, or assertive and generation of assertive responses to
chosen voice or other. Experiential role plays are a critical
part of Phase 3 and are used to explore the motives of the
voice (and other people) and to practice relating in an as-
sertive manner.
The intervention will be offered by five therapists.
Two of the therapists (including the first author) are fa-
miliar with the therapy, having previously delivered it
within the case series [16,20]. The three remaining ther-
apists are experienced in the delivery of psychological
therapy for psychotic experiences within trials, and will
receive training from the first author.
Treatment-as-usual
All participants will be receiving treatment-as-usual from
an NHS mental health service. This will include anti-
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of their clinical team. Participants will be required to have
no definite plan to receive psychological therapy for voices
at the time of consenting to the study. There are no other
requirements for previous or future therapy.
Measures
Primary measure
Psychotic Symptoms Rating Scale (PSYRATS-AHRS) -
an 11-item rating scale designed to measure the severity
of different dimensions of the voice hearing experience
[23]. Items include frequency, duration, loudness, intensity
of distress, and controllability and are grouped together in
four factors [25]; distress (negative content, distress, and
control), frequency (frequency, duration, and disruption),
attribution (location and origin of voices), and loudness
(loudness item only). The authors report excellent psycho-
metric properties [23].
Secondary measures
Choice of outcome in CBT for psychoses (CHOICE) –
CHOICE is a 21-item self-report questionnaire developed
with service users to assess goals for CBT for psychosis
that are relevant to recovery, including self confidence,
ways of dealing with unpleasant feelings and emotions,
positive ways of relating to people, knowing they are not
the only person who has unusual experiences, and a posi-
tive purpose and direction in life [26]. CHOICE has been
found to be reliable and valid.
Voice and You (VAY) - the VAY is a 28-item measure
of interrelating between the hearer and their predomin-
ant voice [15]. Relating is measured across four scales:
two concerning the hearer’s perception of the relating of
the voice (voice dominance and voice intrusiveness), and
two concerning the relating of the hearer (hearer dis-
tance and hearer dependence). The VAY has good in-
ternal consistency (α >0.80 for all scales) and acceptable
test-retest reliability (r >0.7 for all scales).
The Shorter version of the Persons Relating to Others
Questionnaire (PROQ3) - the PROQ3 is a 40-item ques-
tionnaire that assesses relating across eight scales which
correspond to the relating positions within Birtchnell’s
Interpersonal Octagon [27]. The PROQ3 has acceptable
internal consistency (α >0.70 for all scales) and its eight-
factor structure is supported by factor analysis and
multidimensional scaling analysis.
Hospital anxiety and depression scale (HADS) - the
HADS is a 16-item measure of symptoms of anxiety and
depression that has well-established psychometric pro-
perties [28].
Analysis
The aim of this pilot study is to establish: 1) Recruitment,
retention, and follow-up rates to the trial. This will berecorded as: (a) the number of research assistant hours
required to obtain consent for one participant, (b) the
percentage of participants who complete the Time 1 as-
sessment, and (c) the percentage of participants who
complete the Time 2 assessment; 2) Level of adherence
with the treatment. This will be recorded as the percent-
age of participants who complete at least eight RT sessions
(50% of the maximum of 16 sessions); 3) Treatment effect
size relative to treatment-as-usual. A mixed one way ana-
lysis of variance (ANOVA) with post-hoc tests, where ap-
propriate, will be conducted in order to calculate the
group (two levels: RT + TAU or TAU) by time (three
levels: T0, T1 and T2), interaction effect size, and its 95%
confidence interval on the PSYRATS-AHRS; 4) Minimally
clinically important difference. Taking a reduction of 1.0
on a PSYRATS-AHRS item as having clinical meaning, a
difference of 5 in change scores (T0-T1 and T0-T2) be-
tween the two groups for the 5-item distress subscale will
represent a minimally clinically important difference and
be contained within the 95% confidence interval for the
effect size.
This information will be used to refine the therapy
protocol and to design the definitive trial. The group by
time effect size on the PSYRATS-AHRS will be used for
the power calculation for the definitive trial whilst taking
into account the minimum clinically important diffe-
rence on the PSYRATS-AHRS.
Research governance
The study is sponsored by Sussex Partnership NHS
Foundation Trust. NHS ethics (reference number 12/LO/
2045) and R&D approval were sought before the com-
mencement of the trial. Medical Research Council Guide-
lines on Good Clinical Practice in Clinical Trials [29]
informed the constitution of the Trial Steering Commit-
tee, which includes an independent chair, two independ-
ent experts, and a lay person.
Discussion
Evidence for the effectiveness of CBT specifically for dis-
tressing voices is limited and the development of alterna-
tive interventions is warranted [6]. We have contributed
to the development of a literature that explores the experi-
ence of hearing voices within interpersonal frameworks.
Specifically, we have explored voice hearing with respect
to both the power and proximity aspects of relating and
developed RT in order to specifically target these forms of
relating. RT aims to re-balance the hearer-voice relation-
ship (without extremes of power or proximal ways of
relating) and has been found to be safe, acceptable, and in-
tuitively appealing to therapists and hearers within a pre-
vious study [16,20]. This external pilot RCT will generate
a refined study protocol, an indication of recruitment and
retention rates, and an estimate of the effect size, in order
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If evidence from a definitive RCT suggests that RT is
effective, this will extend the range of evidence-based
psychological therapies available to people who hear
distressing voices.
Trial status
Recruitment to the trial commenced in June 2013. At
present, recruitment and data collection will continue
until February 2015.
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